Quantcast

Latest Cancer Research Stories

2014-04-03 08:30:29

- Company to Present Data on SF3B1 Program at a Symposium During the American Association for Cancer Research Annual Meeting 2014 - CAMBRIDGE, Mass., April 3, 2014 /PRNewswire/ -- H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of precision medicines for oncology, announced today that it has named its lead investigational drug candidate for its program that targets SF3B1, a component of the human genetic splicing machinery that has been...

2014-04-03 08:29:00

- More than 50 abstracts highlight breadth and depth of Novartis Oncology pipeline and ability to test various combinations early to target multiple pathways EAST HANOVER, N.J., April 3, 2014 /PRNewswire/ -- Novartis announced today that early stage data on 19 investigational compounds in its oncology pipeline will be presented at the annual meeting of the American Association of Cancer Research (AACR), April 5-9, 2014 in San Diego, CA. The AACR annual meeting highlights basic, translational...

2014-04-02 23:29:06

Bob Lloyd to remain active on the Board of Directors and with the V Wine Celebration. Cary, NC (PRWEB) April 02, 2014 The V Foundation for Cancer Research, one of the nation’s leading cancer research funding organizations, is proud to announce Steve Bornstein as its Board Chair, effective April 1, 2014. Bornstein, most recently the President and CEO of NFL Network and Executive Vice President of Media for the NFL, was selected by The V Foundation after six months of careful and...

2014-04-02 23:22:30

Fully characterized and authenticated cell products assure data reliability and reproducibility. Manassas, VA (PRWEB) April 02, 2014 ATCC, the premier global biological materials resource and standards organization, will feature its comprehensive portfolio of cancer research solutions for the creation of biologically relevant in vitro cancer models during the AACR Annual Meeting 2014 in San Diego, California. ATCC maintains the largest collection of cells lines characterized and...

2014-04-02 16:23:15

DUBLIN, Apr. 02, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gd4n67/global_and ) has announced the addition of the "Global and Chinese Feed Chlortetracycline Industry Report 2014" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The Global and Chinese Feed Chlortetracycline Industry Report 2014 is a professional and in-depth study on the current state of the global feed chlortetracycline industry with a focus on...

2014-04-02 08:32:57

--First-in-Class CLIA Assay for Detection of Tumor-Specific Gene Amplifications Using Circulating Cell-Free DNA-- BALTIMORE, April 2, 2014 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome analyses, today announced the launch of its METDetect(TM) Assay for the detection of MET gene amplifications in the circulation of cancer patients. Amplifications and other structural changes of the MET cancer gene have been associated with resistance to...

2014-04-01 23:32:32

On Sunday, April 6, performing art students in Interlochen, MI will present a collection of music, acting, poetry and dance to benefit the Damon Runyon Cancer Research Foundation. Interlochen, MI (PRWEB) April 01, 2014 Organizers of “I Perform For,” a free cancer benefit concert, announced today they will be presenting their third annual concert this Sunday, April 6, 2014 at 7:30 pm EST. Performing arts enthusiasts can view the invite-only performance online via a live broadcast...

2014-04-01 08:28:44

SAN DIEGO, April 1, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that clinical data from a study using the company's cancer monitoring platform for the detection and longitudinal monitoring of BRAF V600E mutations will be the subject of a late-breaking poster presentation at the American Association for Cancer Research Annual Meeting in San Diego, California....

2014-03-31 08:30:41

Morgan Stanley's Head of Global Biotech Investment Banking Joins Leading Cancer Immunotherapy Startup SEATTLE, March 31, 2014 /PRNewswire/ -- Juno Therapeutics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, announced today that Steve Harr, M.D., will join the company as its Chief Financial Officer and Head of Corporate Development. http://photos.prnewswire.com/prnvar/20140113/DC45426LOGO Harr currently serves as Managing Director and Head of...

2014-03-27 12:30:31

Portion of Proceeds from Connexion 2014 Earmarked to Provide Financial and Emotional Relief for Families and Patients Battling Cancer FOXBORO, Mass., March 27, 2014 /PRNewswire/ -- Axeda Corporation, the leading cloud-based service and software for connecting, building and managing Internet of Things (IoT) solutions, today announced its support of the Joe Andruzzi Foundation (JAF), a Massachusetts-based nonprofit 5019(c)(3) organization dedicated to alleviating cancer's financial and...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'